Surgical Robotics and Computer-assisted Surgery Market Size, Share, Growth, Trends, and Global Industry Analysis: By Offering (Instruments, Surgical Robotic Systems, Services), By Surgical Type (General Surgery, Orthopedic Surgery, Abdominal and Pelvic Surgery, Urologic Surgery, Others), By Application (Therapies/Treatment, Diagnostics), By End-Users (Hospitals, Ambulatory Surgery Centers, Diagnostic Labs) and Region 2020-2031

Surgical Robotics and Computer-assisted Surgery Market size was valued at US$ 4,572.0 million in 2024 and is projected to reach US$ 9,255.3 million by 2031 at a CAGR of 10.6% from 2025-2031. Moreover, the U.S. Surgical Robotics and Computer-assisted Surgery Market is projected to grow at 11.6% over the forecast period. The market encompasses robotic systems, software platforms, and advanced technologies designed to enhance the precision, control, and visualization of surgical procedures. These systems include robotic-assisted platforms for minimally invasive surgeries, computer-aided navigation tools, and image-guided surgery systems. By integrating robotics with real-time data, imaging, and intelligent algorithms, this market aims to improve surgical accuracy, reduce intraoperative complications, and shorten recovery times. The technology is used across various specialties such as urology, orthopedics, neurosurgery, and general surgery, enabling surgeons to perform complex procedures with enhanced dexterity and minimal invasiveness.

The market is witnessing rapid expansion due to rising demand for minimally invasive procedures, growing surgical volumes, and technological advancements in robotic platforms. Companies like Intuitive Surgical, Medtronic, and Stryker are leading innovation through AI-integrated systems, cloud-based analytics, and improved haptic feedback. Hospitals and surgical centers globally are adopting robotic systems to enhance procedural consistency and patient outcomes. Aging populations, increasing prevalence of chronic diseases, and a global shortage of skilled surgeons are also driving adoption. Moreover, favorable regulatory pathways and significant R&D investments are accelerating new product approvals and global market penetration.

Facts & Figures

• As of early 2023, over 7,500 da Vinci surgical systems were installed worldwide, with more than 11 million procedures performed using these platforms globally.
• According to the American Hospital Association and multiple academic reports, large hospitals in the U.S. often conduct hundreds to thousands of robotic-assisted surgeries per year, and roughly 3 out of 4 prostate cancer surgeries in the U.S. today are performed using da Vinci systems.

Key Developments

• In March 2025, SS Innovations International introduced the SSI MantraM Tele Sync Mobile Unit at its Second Global Multi Specialty Robotic Surgery Conference in Gurugram, India. This groundbreaking, first-of-its-kind mobile surgical platform integrates the SSi Mantra 3 surgical robot with high-speed connectivity, enabling expert surgeons to remotely guide procedures in real time. The innovation received regulatory validation from India’s Central Drugs Standard Control Organization (CDSCO) for telesurgery and teleproctoring. It marks a significant leap in expanding access to advanced robotic surgery across remote healthcare centers, reinforcing India’s role as a leader in health tech innovation and remote surgical care.
• In July 2025, Toumai, the endoscopic surgical robot developed by MicroPort/MedBot, received the “Groundbreaking Technology” award at the Surgical Robotics Industry Awards 2025. The recognition celebrated its technological excellence, including its status as the first surgical robot approved globally for remote surgery applications across multiple specialties. Having received regulatory clearance in over 30 countries, Toumai continues to lead innovations in tele-surgical care and multi-specialty applications.

Surgical Robotics and Computer-assisted Surgery Market Segmentation:

Based on the offering

• Instruments
• Surgical Robotics System
• Services

The Surgical Robotics System segment is anticipated to lead the surgical robotics and computer-assisted surgery market, driven by the increased demand for precision, automation, and minimally invasive solutions in complex surgical procedures. These systems represent the technological core of robotic-assisted surgeries, offering advanced features such as 3D visualization, enhanced dexterity, and haptic feedback that significantly improve surgical outcomes. A major driver behind the dominance of this segment is the continuous evolution of robotic platforms to address a broader range of surgical specialties including urology, gynecology, general surgery, and orthopedics. Leading manufacturers are investing in modular, compact, and AI-integrated systems to increase accessibility and reduce operational challenges.

Furthermore, hospitals and surgical centers view these systems as long-term investments that enhance their clinical capabilities and competitiveness. The increasing clinical validation, coupled with growing surgeon preference for robot-assisted procedures, underscores why surgical robotics systems are emerging as the leading contributor within the market’s offerings.

Based on the surgical type

• General Surgery
• Orthopedic Surgery
• Abdominal and Pelvic Surgery
• Urologic Surgery
• Others

The Urologic surgery is anticipated to be the leading segment within the surgical robotics and computer-assisted surgery market, primarily driven by the high precision and minimally invasive benefits that robotic systems offer for delicate procedures such as prostatectomies and nephrectomies. These surgeries often require intricate maneuvers in confined anatomical spaces, where robotic platforms provide enhanced dexterity, superior 3D visualization, and tremor filtration, significantly improving clinical outcomes and reducing patient recovery time. The prevalence of prostate cancer, particularly in aging male populations, is further contributing to the high volume of robotic-assisted urologic procedures.

According to data from the National Institutes of Health (NIH), robotic-assisted radical prostatectomy has become one of the most performed robotic procedures in the United States. Surgeons increasingly prefer robotic systems for urologic applications due to better control over soft tissue handling and reduced blood loss. This growing clinical acceptance and proven patient benefits are establishing urologic surgery as the dominant surgical type in this evolving market.

Based on the application

• Therapies/Treatment
• Diagnostics

The Therapies/Treatment is expected to lead the surgical robotics and computer-assisted surgery market based on application, primarily due to the increased reliance on robotic systems to enhance the precision, safety, and efficiency of surgical interventions. These technologies are playing a transformative role in therapeutic procedures by enabling minimally invasive surgeries that reduce complications, shorten hospital stays, and improve recovery times. Robotic-assisted treatment is especially prominent in complex operations such as cardiac, oncological, and neurological surgeries, where precision is critical. The rising burden of chronic diseases and age-related conditions globally is also increasing the volume of surgeries, thereby boosting the demand for robot-assisted therapeutic interventions.

Additionally, the integration of real-time imaging, AI-guided decision-making, and advanced haptic feedback into surgical robots is improving intraoperative performance and patient outcomes. Healthcare providers are prioritizing robotic treatment technologies to meet growing clinical demands and enhance procedural success rates, positioning therapies and treatments as the leading application segment in this market.

Based on the end-user

• Hospitals
• Ambulatory Surgery Centers
• Diagnostic Labs

The Hospitals are anticipated to be the leading end-user segment in the surgical robotics and computer-assisted surgery market, primarily driven by their advanced infrastructure, higher patient volumes, and greater financial capacity to invest in cutting-edge technologies. Large hospitals, particularly tertiary care and specialty centers are more likely to adopt robotic surgical systems due to their ability to support complex surgical procedures that require high precision and specialized equipment. These institutions often have dedicated surgical teams trained in robotic-assisted techniques, ensuring optimal utilization of such systems.

Furthermore, hospitals benefit from favorable reimbursement policies for robotic procedures in several countries, which enhances their return on investment. The rising demand for minimally invasive surgeries also aligns with hospital objectives to improve patient outcomes and reduce postoperative complications. Many hospitals are expanding robotic surgery programs across various specialties, including cardiology, urology, and oncology, reinforcing their dominant role as the primary adopters and drivers of growth in this evolving market.